Enhancing effect of borneol and muscone on geniposide transport across the human nasal epithelial cell monolayer

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Chen, Zhenzhen ^a   Gong, Xin ^a   Lu, Yang ^a   Du, Shouying ^a   Yang, Zhihui ^b   Bai, Jie ^a   Li, Pengyue ^a   Wu, Huichao ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACTIN; BORNEOL; GENIPOSIDE; MULTIDRUG RESISTANCE PROTEIN; MUSCONE; BORNANE DERIVATIVE; CYCLOALKANE DERIVATIVE; IRIDOID; ISOBORNEOL;

ARTICLE; BLEACHING; CELL MEMBRANE FLUIDITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG TRANSPORT; ELECTRIC RESISTANCE; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MONOLAYER CULTURE; MUCOSA CELL; NASAL EPITHELIAL CELL; NOSE MUCOSA; TRANSCYTOSIS; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ACTINS; BIOLOGICAL TRANSPORT; BORNANES; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOPARAFFINS; EPITHELIAL CELLS; HUMANS; IRIDOIDS; MICROSCOPY, FLUORESCENCE; NASAL MUCOSA;

EID: 84903784850     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101414     Document Type: Article

References (45)

1. Wu SY, Wang GF, Liu ZQ, Rao JJ, Lu L, et al. (2009) Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Acta Pharmacol Sin 30: 202-208.
2. Lu Y, Du S, Bai J, Li P, Wen R, et al. (2012) Bioavailability and brain-targeting of geniposide in gardenia-borneol co-compound by different administration routes in mice. Int J Mol Sci 13: 14127-14135.
3. Hanson LR, Fine JM, Svitak AL, Faltesek KA (2013) Intranasal administration of CNS therapeutics to awake mice. J Vis Exp.
4. Pardeshi CV, Belgamwar VS (2013) Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv.
5. McMartin C, Hutchinson LE, Hyde R, Peters GE (1987) Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J Pharm Sci 76: 535-540.
6. Ugwoke MI, Verbeke N, Kinget R (2001) The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 53: 3-21. (Pubitemid 32140298)
7. Reitz M, Demestre M, Sedlacik J, Meissner H, Fiehler J, et al. (2012) Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma. Stem Cells Transl Med 1: 866-873.
8. Renner DB, Svitak AL, Gallus NJ, Ericson ME, Frey WH 2nd, et al. (2012) Intranasal delivery of insulin via the olfactory nerve pathway. J Pharm Pharmacol 64: 1709-1714.
9. Yang JP, Liu HJ, Cheng SM, Wang ZL, Cheng X, et al. (2009) Direct transport of VEGF from the nasal cavity to brain. Neurosci Lett 449: 108-111.
10. Johnson NJ, Hanson LR, Frey WH (2010) Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures. Mol Pharm 7: 884-893.
11. Cui Y, Li L, Zhang L, Li J, Gu J, et al. (2011) Enhancement and mechanism of transdermal absorption of terpene-induced propranolol hydrochloride. Arch Pharm Res 34: 1477-1485.
12. Cai Z, Hou S, Li Y, Zhao B, Yang Z, et al. (2008) Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration. J Drug Target 16: 178-184. (Pubitemid 351266554)
13. Li Z, Sun D, Yang H, Liu X, Luan L, et al. (2010) Effect of borneol on the distribution of danshensu to the eye in rabbit via oral administration. Curr Eye Res 35: 565-572.
14. Lu Y, Du SY, Chen XL, Wu Q, Song X, et al. (2011) Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration. J Zhejiang Univ Sci B 12: 143-148.
15. Merkle HP, Ditzinger G, Lang SR, Peter H, Schmidt MC (1998) In vitro cell models to study nasal mucosal permeability and metabolism. Adv Drug Deliv Rev 29: 51-79. (Pubitemid 28044086)
16. Dimova S, Brewster ME, Noppe M, Jorissen M, Augustijns P (2005) The use of human nasal in vitro cell systems during drug discovery and development. Toxicol In Vitro 19: 107-122. (Pubitemid 39592983)
17. Forbes B, Ehrhardt C (2005) Human respiratory epithelial cell culture for drug delivery applications. Eur J Pharm Biopharm 60: 193-205. (Pubitemid 40804561)
18. Illum L (1996) Nasal delivery. The use of animal models to predict performance in man. J Drug Target 3: 427-442.
19. Yoo JW, Kim YS, Lee SH, Lee MK, Roh HJ, et al. (2003) Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies. Pharm Res 20: 1690-1696.
20. Kadan S, Saad B, Sasson Y, Zaid H (2013) In Vitro Evaluations of Cytotoxicity of Eight Antidiabetic Medicinal Plants and Their Effect on GLUT4 Translocation. Evid Based Complement Alternat Med 2013: 549345.
21. Portnoy E, Gurina M, Magdassi S, Eyal S (2012) Evaluation of the Near Infrared Compound Indocyanine Green as a Probe Substrate of P-Glycoprotein. Mol Pharm.
22. Vadlapudi AD, Vadlapatla RK, Kwatra D, Earla R, Samanta SK, et al. (2012) Targeted lipid based drug conjugates: a novel strategy for drug delivery. Int J Pharm 434: 315-324.
23. Yoo J-W, Kim Y-S, Lee S-H, Lee M-K, Roh H-J, et al. (2003) Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies. Pharmaceutical research 20: 1690-1696. (Pubitemid 37268288)
24. van Woensel M, Wauthoz N, Rosiere R, Amighi K, Mathieu V, et al. (2013) Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? Cancers (Basel) 5: 1020-1048.
25. Agu RU, Vu Dang H, Jorissen M, Willems T, Kinget R, et al. (2002) Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium. Int J Pharm 237: 179-191. (Pubitemid 34310491)
26. Ugwoke MI, Agu RU, Jorissen M, Augustijns P, Sciot R, et al. (2000) Toxicological investigations of the effects carboxymethylcellulose on ciliary beat frequency of human nasal epithelial cells in primary suspension culture and in vivo on rabbit nasal mucosa. Int J Pharm 205: 43-51.
27. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
28. Lin H, Li H, Cho HJ, Bian S, Roh HJ, et al. (2007) Air-liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies. J Pharm Sci 96: 341-350. (Pubitemid 46363565)
29. Lehrner J, Marwinski G, Lehr S, Johren P, Deecke L (2005) Ambient odors of orange and lavender reduce anxiety and improve mood in a dental office. Physiol Behav 86: 92-95. (Pubitemid 41316611)
30. Gabbanini S, Lucchi E, Carli M, Berlini E, Minghetti A, et al. (2009) In vitro evaluation of the permeation through reconstructed human epidermis of essentials oils from cosmetic formulations. J Pharm Biomed Anal 50: 370-376.
31. Zhou Y, Li W, Chen L, Ma S, Ping L, et al. (2010) Enhancement of intestinal absorption of akebia saponin D by borneol and probenecid in situ and in vitro. Environ Toxicol Pharmacol 29: 229-234.
32. Chen WK, Huang YF, Wang HD (2004) [An experimental study on distribution of musk into the brain through blood brain barrier]. Zhong Xi Yi Jie He Xue Bao 2: 288-291.
33. Wang N, Chang GJ, Jin QZ, He Q, Liu JS, et al. (2012) [Analysis of muscone from serum and cerebrospinal fluid of rabbits after intragastric administration of tongqiao huoxue granules]. Zhong Yao Cai 35: 1291-1294.
34. Davis SS, Illum L (2003) Absorption enhancers for nasal drug delivery. Clin Pharmacokinet 42: 1107-1128. (Pubitemid 37357648)
35. Paris L, Tonutti L, Vannini C, Bazzoni G (2008) Structural organization of the tight junctions. Biochim Biophys Acta 1778: 646-659. (Pubitemid 351317797)
36. Hall A (1998) Rho GTPases and the actin cytoskeleton. Science 279: 509-514.
37. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, et al. (2003) Cell migration: integrating signals from front to back. Science 302: 1704-1709. (Pubitemid 37505725)
38. Werner U, Kissel T (1995) Development of a human nasal epithelial cell culture model and its suitability for transport and metabolism studies under in vitro conditions. Pharm Res 12: 565-571.
39. Ghaffarian R, Muro S (2013) Models and methods to evaluate transport of drug delivery systems across cellular barriers. J Vis Exp.
40. Alvarez-Berrios MP, Castillo A, Mendez J, Soto O, Rinaldi C, et al. (2013) Hyperthermic potentiation of cisplatin by magnetic nanoparticle heaters is correlated with an increase in cell membrane fluidity. Int J Nanomedicine 8: 1003-1013.
41. Vilas-Boas V, Silva R, Nunes C, Reis S, Ferreira L, et al. (2013) Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin. Toxicol Lett 220: 259-266.
42. Haratake M, Takahira E, Yoshida S, Osei-Asante S, Fuchigami T, et al. (2013) Improved membrane fluidity of ionic polysaccharide bead-supported phospholipid bilayer membrane systems. Colloids Surf B Biointerfaces 107: 90-96.
43. Qi H-P, Gao X-C, Zhang L-Q, Wei S-Q, Bi S, et al. (2013) In vitro evaluation of enhancing effect of borneol on transcorneal permeation of compounds with different hydrophilicities and molecular sizes. European journal of pharmacology 705: 20-25.
44. Chen Z-Z, Lu Y, Du S-Y, Shang K-X, Cai C-B (2013) Influence of borneol and muscone on geniposide transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model. International journal of pharmaceutics 456: 73-79.
45. Chen Y, Wang N (2004) Effect of borneol on the intercellular tight junction and pinocytosis vesicles in vitro blood-brain barrier model. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine/Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban 24: 632.